John G. Ullman & Associates Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$3.88M |
| 2 |
Flowserve
FLS
|
+$3.34M |
| 3 |
Abbott
ABT
|
+$2.52M |
| 4 |
GXP
Great Plains Energy Incorporated
GXP
|
+$2.47M |
| 5 |
Watts Water Technologies
WTS
|
+$2.26M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
STJ
St Jude Medical
STJ
|
+$5.9M |
| 2 |
Applied Materials
AMAT
|
+$5.05M |
| 3 |
MENT
Mentor Graphics Corp
MENT
|
+$4.5M |
| 4 |
Corning
GLW
|
+$4.34M |
| 5 |
Chemung Financial Corp
CHMG
|
+$3.09M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 26.5% |
| 2 | Industrials | 19.24% |
| 3 | Technology | 16.19% |
| 4 | Energy | 9.31% |
| 5 | Utilities | 7.74% |
Similar funds
John G. Ullman & Associates's Q1 2017 Portfolio in Review
As of Q1 2017, John G. Ullman & Associates held 129 positions worth $484M, up 1.3% from $477M the previous quarter. Its ten largest holdings account for 34% of the portfolio.
John G. Ullman & Associates withdrew a net $15.1M in Q1 2017, closing 12 positions and reducing 67 holdings. Its most notable exit was St Jude Medical, an estimated $5.9M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 27% of assets, up from 26% a quarter earlier, followed by Industrials and Technology.
Against the trend, John G. Ullman & Associates opened a new position in Conduent worth $1.56M.
- John G. Ullman & Associates's largest Q1 2017 buy was Conduent: 92,776 shares worth $1.56M.
- John G. Ullman & Associates added most to ExxonMobil in Q1 2017, an estimated $3.88M increase.
- John G. Ullman & Associates's biggest Q1 2017 reduction was Corning, cutting an estimated $4.34M.
- John G. Ullman & Associates fully exited St Jude Medical in Q1 2017, selling an estimated $5.9M.
- John G. Ullman & Associates's ten largest holdings make up 34% of its $484M portfolio in Q1 2017.
- John G. Ullman & Associates opened 9 new positions and closed 12 in Q1 2017.
- John G. Ullman & Associates's portfolio value rose 1.3% quarter-over-quarter to $484M.
Based on John G. Ullman & Associates's 13F filing for Q1 2017, filed 25 Apr 2017.